# Disior

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/disior

- Industry: Software
- Headquarters: Helsinki, Finland
- Website: www.disior.com
- Total disclosed funding: $0.7M
- Latest round: Seed (Mar 16, 2018)
- Investors on record: 1

## About

Disior Ltd. is a Finnish technology company that specializes in advanced 3D medical imaging software, enabling healthcare professionals to automate segmentation and enhance analysis of human anatomies for improved patient care.Founded in 2016 and headquartered in Helsinki, Finland, Disior Ltd. focuses on developing innovative medical imaging solutions. The company has undergone a strategic pivot to enhance its technological offerings. It has received funding primarily through a SEED round, raising EUR 0.600 mn led by Maki.vc, contributing to its total amount raised of EUR 0.600 mn. The most recent funding round took place on January 12, 2022, when Disior was acquired by Paragon 28, Inc., although specific financial details of this acquisition remain undisclosed. Anna-Maria Henell is the current CEO, leading the company through its growth trajectory.Disior specializes in the development of advanced 3D medical imaging software designed specifically for clinicians. Their core product offering focuses on automated segmentation and three-dimensional analysis of human anatomies, which supports healthcare professionals in making more accurate diagnoses and treatment plans. This technology is particularly beneficial in fields such as radiology and surgery, where precise visualization of anatomical structures is essential. Disior's software is utilized in various international markets, including Europe, North America, and parts of Asia, catering to a diverse client base that encompasses hospitals, diagnostic imaging centers, and individual healthcare practitioners. The end users of Disior's products are primarily medical professionals who seek to enhance their imaging capabilities and improve patient outcomes through advanced visualization tools.In 2023, Disior reported a revenue of EUR 132,106.40 with an EBITDA of EUR -2,376,169.70. The company generates revenue through a direct business-to-business model, focusing on subscriptions and partnerships with healthcare institutions. Clients typically enter into agreements that provide them with access to Disior's software licenses, which may include ongoing support and updates as part of the subscription package.Disior is actively working on developing new products aimed at enhancing their medical imaging capabilities, with plans for future releases that align with market needs. The company is exploring expansion into new geographical markets, particularly targeting additional regions in Europe and North America by 2024. The funding raised in the SEED round will support these initiatives, as well as continued investment in product development and market penetration strategies.

## Funding rounds

- Seed, Mar 16, 2018, $0.7M — Maki.vc

## Investors

- Maki.vc (https://capitalatlas.ai/funds/maki-vc) — Seed